Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinovac Also Receives OK for EV71 Vaccine Trials

publication date: Dec 28, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinovac Biotech was granted SFDA approval to begin clinical trials of an inactivated vaccine for EV71, also known as Hand, Foot and Mouth Disease (HFMD). Yesterday, China Biologic also announced approval for trials of a similar HFMD vaccine. Sinovac, which filed for an IND in December 2009, has been waiting for a year for official permission to begin the clinical phase of development. More details....

Stock Symbol: (NSDQ: SVA)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Alibaba IPO
Event Updates
Greg Scott will be attending and speaking at these events:
 
 
 
Hope to see you there!
 
ChinaBio® Events
More events coming soon...

>> More events...

Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors